Screener
Maravai LifeSciences Holdings, Inc. MRVI Cygnus — Sales & Marketing
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001823239-26-000059
FAQ
- What is Maravai LifeSciences Holdings, Inc.'s cygnus — sales & marketing?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported cygnus — sales & marketing of $821K in Q2 2026.
- How has Maravai LifeSciences Holdings, Inc.'s cygnus — sales & marketing changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s cygnus — sales & marketing increased by 10.2% year-over-year, from $745K to $821K.
- What does cygnus — sales & marketing mean?
- Includes all expenses related to the promotion, advertising, and sales force activities dedicated to the Biologics Safety Testing segment. This metric measures the investment required to acquire and retain customers in the competitive life sciences market. It is essential for assessing the segment's customer acquisition cost and market expansion strategy.
Ask your AI about Maravai LifeSciences Holdings, Inc.'s cygnus — sales & marketing.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude